|
Sergeeva O.S., Salamatova V.N., Kotova Yu.A., Shevtsov A.N., Shevtsova V.I.
Influence of hyperuricemia at the efficacy of hypolypidemic therapy in patients with chronic forms of ischemic heart disease
|
№6 / 2024
|
|
Garanin A.A., Lebedev P.A., Paranina E.V.
Hereditary gout in a young woman with allopurinol intolerance
|
№6 / 2023
|
|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
|
Gaydukova I.Z., Mazurov V.I., Inamova O.V., Zinserling A.Yu., Bashkinov R.A.
Increasing of glomeral filtration rate in the setting of serum uric acid normalization in high cardiovascular risk patients – clinical observations
|
№3 / 2023
|
|
Maksudova A.N., Khalfina T.N., Almukhametova A.I.
Patient with hyperuricemia and chronic kidney disease is at the doctor: Peculiarities of curation in accordance with Russian recommendations
|
№3 / 2023
|
|
Borovkova N.Yu., Kurashin V.K., Tokareva A.S., Makarova E.V., Nekrasov A.A., Savitskaya N.N., Mironov M.A.
Hyperuricemia and reduced glomerular filtration rate in the population among Nizhny Novgorod region inhabitants
|
№3 / 2023
|
|
Larina V.N., Fedorova E.V., Sayno O.V., Mironova T.N., Orlov D.A.
The incidence of abdominal obesity and its association with risk factors for cardiovascular disease in middle-aged people
|
№8 / 2022
|
|
Shchemeleva E.V., Skorodumova E.A.
Adherence to therapy in patients with gout
|
№8 / 2021
|
|
Pereverzev A.P., Ostroumova O.D.
Drug-induced hyperuricemia/gout. Part 1: prevalence, pathophysiology, risk factors, clinical pattern
|
№6 / 2021
|
Русский
